Ready-to-Use Luria-Bertani (LB) Liquid Medium Market Report 2026

The ready-to-use luria-bertani (lb) liquid medium market size has grown strongly in recent years. It will grow from $11.21 billion in 2025 to $12.16 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to expansion of microbiology research laboratories, growth in academic life sciences programs, increasing use of bacterial cultures in research, availability of standardized lab consumables, rising demand for reproducible experiments.

The ready-to-use luria-bertani (lb) liquid medium market size is expected to see strong growth in the next few years. It will grow to $16.63 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing adoption of automated microbiology workflows, rising demand from biopharmaceutical research, expansion of synthetic biology applications, growing focus on contamination-free media, increasing outsourcing of laboratory research. Major trends in the forecast period include increasing adoption of ready-to-use culture media, rising demand for consistent microbial growth solutions, growing use in high-throughput laboratories, expansion of pre-sterilized media products, enhanced focus on time-efficient lab workflows.

The growing emphasis on research and development is expected to drive the expansion of the ready-to-use Luria-Bertani (LB) liquid medium market in the coming years. Research and development activities involve exploring new ideas or technologies and applying the findings to develop or enhance products or processes through design, testing, and refinement. The goal of continuous innovation compels companies to invest in R&D to create new products, enhance existing ones, and stay competitive by addressing evolving consumer demands. Ready-to-use LB liquid medium plays a critical role in R&D as it supports bacterial growth, gene cloning, protein expression, and other genetic modifications. Its convenience and reliability make it indispensable for a wide range of experimental methods and large-scale research applications. For example, in September 2025, the National Science Foundation (NSF), a U.S.-based government agency, reported that businesses continued to boost their research and development efforts in 2023, investing $722 billion in R&D in the United States, marking a 4.4% increase from 2022. Consequently, the rise in research and development activities propels the growth of the ready-to-use Luria-Bertani (LB) liquid medium market.

The increasing number of clinical trials is anticipated to drive the growth of the ready-to-use Luria-Bertani (LB) liquid medium market in the coming years. A clinical trial is a research study involving human participants to evaluate the safety and efficacy of a new medical intervention before it becomes widely available. The rise in clinical trials is fueled by the growing demand for personalized medicine, which seeks to develop treatments tailored to individual genetic profiles and specific health conditions. Clinical trials require consistent conditions to ensure accurate results, and ready-to-use LB liquid medium provides this reliability without the need for preparation or sterilization. This convenience accelerates the research process, especially in high-throughput and multi-site studies. For example, in December 2024, according to the Association of the British Pharmaceutical Industry, a UK-based nonprofit organization, the number of industry-initiated clinical trials in the UK increased from 411 trials in 2022 to 426 trials in 2023, representing a 3.7% growth. Consequently, the growing number of clinical trials is supporting the expansion of the ready-to-use Luria-Bertani (LB) liquid medium market.

Key players in the ready-to-use Luria-Bertani (LB) liquid medium market are concentrating on advancements in drug discovery software to maintain a competitive advantage. For instance, in December 2023, Merck, a Germany-based pharmaceutical and biotechnology company, introduced AIDDISON, an advanced drug discovery software that leverages artificial intelligence and machine learning algorithms to expedite the identification of potential drug candidates. AIDDISON offers a user-friendly interface and sophisticated data analysis capabilities, enabling researchers to efficiently process and interpret large datasets. This innovative software has the potential to transform the drug discovery process, ultimately facilitating faster and more cost-effective development of new therapeutics.

Major companies operating in the ready-to-use luria-bertani (lb) liquid medium market are Thermo Fisher Scientific Inc., Avantor Inc., Lonza Group AG, Sigma Aldrich Chemicals Pvt. Ltd., Bio-Rad Laboratories Inc., Neogen Corporation, Hardy Diagnostics Inc., MP Biomedicals LLC, Alpha Teknova Inc., HiMedia Laboratories Pvt. Ltd., Scharlab S.L., Interchim, Condalab, Quality Biological Inc., Thomas Scientific LLC, Geno Technology Inc., Central Drug House (P) Ltd., Citotest Labware Manufacturing Co. Ltd., Research Products International, NZYTech Lda.

Europe was the largest region in the ready-to-use Luria-Bertani (LB) liquid medium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ready-to-use luria-bertani (lb) liquid medium market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ready-to-use luria-bertani (lb) liquid medium market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the ready-to-use luria-bertani liquid medium market by increasing costs of imported raw materials, packaging components, sterile containers, and quality control supplies used in media preparation. Research laboratories and biopharmaceutical facilities in North America and Europe are most affected due to reliance on imported consumables, while Asia-Pacific faces cost pressures in bulk media exports. These tariffs are raising per-unit media costs and affecting procurement budgets. However, they are also supporting domestic media manufacturing, localized supply chains, and improved availability of regionally produced ready-to-use culture media.

The ready-to-use luria-bertani (lb) liquid medium market research report is one of a series of new reports that provides ready-to-use luria-bertani (lb) liquid medium market statistics, including ready-to-use luria-bertani (lb) liquid medium industry global market size, regional shares, competitors with a ready-to-use luria-bertani (lb) liquid medium market share, detailed ready-to-use luria-bertani (lb) liquid medium market segments, market trends and opportunities, and any further data you may need to thrive in the ready-to-use luria-bertani (lb) liquid medium industry. This ready-to-use luria-bertani (lb) liquid medium market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Ready-to-use Luria-Bertani (LB) liquid medium is a pre-mixed, nutrient-rich solution for growing various bacterial species. It includes tryptone, yeast extract, and sodium chloride, and requires no additional preparation or sterilization. This medium supports bacterial growth and maintenance in labs, offering a convenient, time-saving solution that ensures consistent results in experiments.

The main types of ready-to-use Luria-Bertani (LB) liquid medium are antibiotic-containing and antibiotic-free. Ready-to-use LB (Luria-Bertani) liquid mediums formulated with antibiotics help suppress the growth of unwanted microorganisms, allowing only the target bacteria to proliferate. They are employed in numerous applications, including drug discovery, stem cell technologies, regenerative medicine and tissue engineering, biopharmaceuticals, cancer research, and more, and are utilized by a range of end-users such as research laboratories, academic institutions, and the biotechnology and pharmaceutical industries.

The ready-to-use Luria-Bertani (LB) liquid medium market consists of sales of bacterial growth medium, cell culture medium, transformation medium, and research medium. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.